Kymera Therapeutics Inc (NAS:KYMR)
$ 50.94 1.09 (2.19%) Market Cap: 3.30 Bil Enterprise Value: 2.84 Bil PE Ratio: 0 PB Ratio: 3.69 GF Score: 50/100

Kymera Therapeutics Inc Investor Webcast KT-474 Clinical Update Call Transcript

Dec 14, 2022 / 01:00PM GMT
Release Date Price: $29.62 (+14.58%)
Bruce N. Jacobs
Kymera Therapeutics, Inc. - CFO

First, I would like to thank everyone for joining us this morning at this busy time as we approach the holidays. We very much appreciate you taking the time to be here for this update, which we're excited to share with you all. As you have noticed by now, we're using a different format for this call, making use of the video cameras to which you all have been accustomed. I'm here in 1 of the conference rooms in the Kymera offices in Watertown, and Nello and Jared are in their respective offices here at Kymera as well.

After some prepared remarks from Nello and Jared, they will join me here in this room, and we'll turn the call over to questions from our covering analysts. We will be sharing a slide deck on this call. We plan to post that to our website after we wrap our presentation, which we plan to conclude by around 9:30 AM, and the 3 of us will also be available throughout the day for follow up.

At this time, before we get started, I'd like to just remind everyone of our forward-looking statement language. The comments that management

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot